News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

Starpharma Holdings Ltd Signs Research Agreement With Unilever (UN) For Dendrimer Technology


4/7/2008 2:37:45 PM

Perth, Apr 7, 2008 (ABN Newswire) - Starpharma Holdings Ltd (ASX:SPL)(OTCQX: SPHRY) today announced the signing of an agreement with Unilever, to co-develop a research tool using Starpharma's Priostar(R) dendrimer technology. An undisclosed fee is payable to Starpharma's US subsidiary DNT Inc as part of the arrangement.

Read at ABN Newswire

comments powered by Disqus
   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES